Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failureJ E Benjamin, G L Chen, T M Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allograftsBoglarka Gyurkocza, Thai M Cao, Rainer F Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphomaJ C Alvarnas, R S Negrin, S J Horning, et al.
Nature Communications|May 10, 2017
Foxp3<sup>+</sup> regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesisAntonio Pierini, Hidekazu Nishikii, Jeanette Baker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2015
ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantationAaron C Logan, Zhiyu Wang, Kamran Alimoghaddam, et al.
Blood|December 2, 2004
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell doseThai M Cao, Judith A Shizuru, Ruby M Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantationGinna G Laport, Kevin Sheehan, Jeanette Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignanciesC R Kusnierz-Glaz, P G Schlegel, R M Wong, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failureJ E Benjamin, G L Chen, T M Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allograftsBoglarka Gyurkocza, Thai M Cao, Rainer F Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphomaJ C Alvarnas, R S Negrin, S J Horning, et al.
Nature Communications|May 10, 2017
Foxp3<sup>+</sup> regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesisAntonio Pierini, Hidekazu Nishikii, Jeanette Baker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2015
ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantationAaron C Logan, Zhiyu Wang, Kamran Alimoghaddam, et al.
Blood|December 2, 2004
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell doseThai M Cao, Judith A Shizuru, Ruby M Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantationGinna G Laport, Kevin Sheehan, Jeanette Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignanciesC R Kusnierz-Glaz, P G Schlegel, R M Wong, et al.
Pageof 26